Last Updated: June 17, 2026

Suppliers and packagers for MOTRIN IB


✉ Email this page to a colleague

« Back to Dashboard


MOTRIN IB

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Kenvue Brands MOTRIN IB ibuprofen TABLET;ORAL 019012 NDA Navajo Manufacturing Company Inc. 67751-120-01 1 POUCH in 1 CARTON (67751-120-01) / 2 TABLET, FILM COATED in 1 POUCH 2016-09-22
Kenvue Brands MOTRIN IB ibuprofen TABLET;ORAL 019012 NDA Navajo Manufacturing Company Inc. 67751-120-02 2 POUCH in 1 CARTON (67751-120-02) / 2 TABLET, FILM COATED in 1 POUCH 2016-09-22
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for MOTRIN IB

Last updated: May 31, 2026

MOTRIN IB (ibuprofen) Suppliers: Who Manufactures, Who Fills, and What to Check in the Supply Chain

MOTRIN IB is a brand of ibuprofen (OTC oral solid). “Suppliers” in a regulatory sense typically map to (1) FDA-registered drug manufacturing sites, (2) label holders/market authorization holders, and (3) contract manufacturers and packagers shown on FDA records and commercial catalogs. For MOTRIN IB, no complete, citable supplier roster can be produced from the information provided.

What companies supply MOTRIN IB (ibuprofen) in the U.S.?

No supplier list can be produced without an authoritative match between the specific product (strength, dosage form, pack configuration, and label holder) and the corresponding FDA establishment and listing records.

Which supplier categories matter for MOTRIN IB procurement?

For OTC ibuprofen products, purchasing due diligence usually focuses on:

  • API manufacturing sites (if disclosed in procurement documentation)
  • Drug product manufacturing sites (tablet/capsule manufacturing)
  • Packaging and secondary operations (bottle, blister, cartons)
  • Quality systems aligned to OTC manufacturing expectations

Which FDA-registered facilities manufacture ibuprofen tablets under the MOTRIN IB brand?

A facility-to-brand mapping requires the exact NDC(s) for MOTRIN IB and then cross-referencing:

  • FDA Drug Establishment Registration and Listing
  • FDA Orange Book entries (if applicable to the specific OTC product format; many OTCs are not listed in the Orange Book)
  • Recent annual GMP inspection relationships for the manufacturing sites

No NDC-level identification is present, so a facility list would be incomplete.

What is the Orange Book status of MOTRIN IB and does it affect supplier visibility?

OTC ibuprofen products often do not have meaningful Orange Book exclusivity disclosures comparable to prescription drugs, and Orange Book visibility is product- and pathway-specific. Without product-level data, the Orange Book status cannot be stated.

Who is the labeler/holder for MOTRIN IB and how does that determine sourcing?

Labeler and holder determine which suppliers are used contractually, but the holder identity must be tied to the exact SKU. Without that, supplier attribution would be speculative.

Do contract manufacturers supply MOTRIN IB generics or store-brand ibuprofen under the same manufacturing sites?

Supply chain overlap is common for OTC ibuprofen across brands and private label, but determining overlap requires:

  • matching establishment registrations
  • matching NDCs
  • confirming whether the same sites produce for multiple labelers

No NDC or establishment data is available here.

When do MOTRIN IB sourcing changes occur (FDA updates, site transfers, relabeling)?

OTC sourcing changes follow:

  • facility transfers and contract renewals
  • packaging line switches
  • labeler/holder changes and relisting updates

A dated timeline needs FDA establishment history tied to MOTRIN IB NDC(s).

What patent estate or exclusivity protects MOTRIN IB and does it constrain suppliers?

Ibuprofen has long-standing off-patent status in most jurisdictions, so patent constraints on manufacturing are typically low for OTC formats, but:

  • formulation-specific or packaging-specific IP can exist
  • import/export constraints can exist even without exclusivity

No MOTRIN IB-specific IP dossier is included in the prompt, so this cannot be stated as fact.

Which generic or OTC ibuprofen competitors use the same supplier network?

Competitor supplier overlap requires establishment and NDC mapping. Without product identifiers, a defensible competitor-supplier network cannot be built.

Key Takeaways

  • A reliable “supplier list” for MOTRIN IB requires exact product identifiers (NDC/SKU, strength, dosage form, package type) and FDA listing mappings.
  • Those inputs are not provided, so generating a supplier roster would not meet a defensible, citation-based patent and regulatory analysis standard.

FAQs

  1. How do I identify MOTRIN IB suppliers from FDA records? Map MOTRIN IB NDC(s) to FDA listing and establishment registrations, then extract the registered manufacturing/packaging sites.
  2. Does Orange Book listing help find MOTRIN IB manufacturers? Only if the specific product is listed and the record includes relevant product identifiers tied to manufacturing details.
  3. Are MOTRIN IB tablets typically made by contract manufacturers? OTC oral solids are frequently produced via contract packaging or manufacturing, but confirmation requires NDC-to-establishment linkage.
  4. How can I tell whether two ibuprofen brands share the same manufacturing site? Compare FDA registered establishment identifiers used for each product’s NDC(s).
  5. What documentation should a buyer request to qualify MOTRIN IB suppliers? GMP inspection status, executed manufacturing agreements, batch records, CoA/CoC, and FDA establishment alignment for the specific NDCs.

References

  1. FDA. Drug Registration and Listing System. U.S. Food and Drug Administration.
  2. FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.